Jiangsu Hengrui Medicine Co., Ltd.

China


 
Total IP 784
Total IP Rank # 1,617
IP Activity Score 3.4/5.0    563
IP Activity Rank # 1,300
Stock Symbol 600276 (sse)
ISIN CNE0000014W7
Market Cap. 224.605B  (CNY)
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

172 2
134 0
473 3
0
 
Last Patent 2024 - Use of combination of anti-pd-1 ...
First Patent 2003 - Sulfonyl-containing 3,4-diaryl-3...
Last Trademark 2010 - Hr
First Trademark 2010 - Hr

Subsidiaries

1 subsidiaries without IP

 Register for free to unlock the subsidiary list

Industry (Nice Classification)

Latest Inventions, Goods, Services

2023 Invention Use of combination of anti-pd-1 antibody and vegfr inhibitor in preparation of drug for treating ...
2022 Invention Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (rory) and phar...
Invention Il-5 antibody, antigen binding fragment thereof, and medical application therefor. Provided are ...
2021 Invention Nitrogen-containing bridged heterocyclic compound, preparation method therefor, and medical use t...
Invention Purinone compound, preparation method therefor, and pharmaceutical application thereof. A purinon...
Invention Crystal form of pyrimido five-membered nitrogen heterocyclic derivative and preparation method th...
Invention Use of nk1 antagonist prodrug compound in combination with 5-ht3 receptor antagonist. The present...
Invention Complex of anti-il-4r antibody or antigen-binding fragment thereof and medical use thereof. Provi...
Invention Purinone derivative, preparation method therefor, and application thereof in medicine. A purinone...
Invention Pharmaceutically acceptable salt of indazole derivative, and crystalline form and preparation met...
Invention Application of jak inhibitor in kidney disease. Provided is an application of a JAK inhibitor in ...
Invention Pharmaceutical composition for pulmonary delivery. A dry powder particle for pulmonary delivery, ...
Invention Machine learning-based peptide immunogenicity prediction and identification system and method. A ...
Invention Pharmaceutical composition comprising anti-connective tissue growth factor antibody. Provided is ...
Invention Multispecific antigen binding protein. Provided is a multispecific antigen binding protein. Provi...
Invention Antibody capable of binding to thymic stromal lymphopoietin, and use thereof. The present inventi...
Invention Pyrimidinedione derivative, preparation method therefor, and medical use thereof. Provided are a ...
Invention Anti-tslp antibody pharmaceutical composition and use thereof. Provided are a pharmaceutical comp...
Invention Drug conjugate of eribulin derivative, preparation method therefor and application thereof in med...
Invention Anti-angptl3 antibody and use thereof. The present invention relates to an anti-ANGPTL3 antibody...
Invention Cephalosporin antibacterial compound and pharmaceutical application thereof. Provided are a ceph...
Invention Anti-trop-2 antidody-exatecan analog conjugate and medical use thereof. Provided in the present ...
Invention Tricyclic tetrahydroisoquinoline derivative, preparation method therefor and application thereof ...
Invention New polypeptide complex. The present disclosure relates to a new polypeptide complex. Specifical...
2020 Invention Crystal form of pyridopyrimidine derivative and preparation method thereof. The present disclosu...
Invention Jak kinase inhibitor pharmaceutical composition. A JAK kinase inhibitor pharmaceutical compositi...
Invention Anti-cea antibody-exatecan analog conjugate and pharmaceutical use thereof. An anti-CEA antibody...
Invention Anti-claudin antibody-drug conjugate and pharmaceutical use thereof. An anti-claudin antibody-dr...
Invention Echinocandin analogues and preparation method therefor. The present invention relates to an echi...
Invention Fused pyridine ring derivative, preparation method therefor, and pharmaceutical use thereof. A f...
Invention Pyrazolo-heteroaryl derivative, preparation method therefor, and medical use thereof. Disclosed ...
Invention Acid addition salt of rory regulator. An acid addition salt of a RORγ regulator. Specifically re...
Invention Method for treating autoimmune disease by il-17 antagonist. The present application relates to a...
Invention Neurokinin-1 antagonist. A compound represented by formula II or a pharmaceutically acceptable s...
Invention Sustained-release lipid composition and preparation method therefor. Disclosed are a sustained-r...
Invention Anti-cea antibody and application thereof. Provided is an anti-CEA antibody comprising a heavy c...
Invention Indazole derivative, preparation method therefor, and pharmaceutical application thereof. An ind...
Invention Antibody capable of binding to thymic stromal lymphopoietin and use thereof. Disclosed are an an...
Invention Anti-connective tissue growth factor antibody and application thereof. Provided are an anti-CTGF...
Invention Solid dispersion and preparation method therefor. Solid dispersion and a preparation method ther...
Invention Anti-claudin 18.2 antibody and application thereof. The present disclosure relates to an anti-Cl...
Invention Thienoheterocyclic derivative, preparation method therefor and medical use thereof. Provided are...
Invention Pyrroloheterocyclic derivative, preparation method therefor, and application thereof in medicine....
Invention Bispecific antibody specifically bound to vegf and ang2. The present disclosure provides a bispe...
Invention Bifunctional fusion protein and pharmaceutical use thereof. Provided are a bifunctional fusion p...
2019 Invention Cd3 antibody and pharmaceutical use thereof. The present disclosure relates to a CD3 antibody an...
Invention Anti-cd73 antibody, antigen-binding fragment thereof and application thereof. Provided are an an...
Invention Use of anti-pd-1 antibody in combination with famitinib in preparation of drug for treating tumor...
Invention Anti-cd38 antibody, antigen-binding fragment thereof, and pharmaceutical use. The present applic...
Invention Isolated chimeric antigen receptor, modified t cell comprising same and use thereof. An isolated...
2017 G/S Injection for pharmaceutical purposes; troche for pharmaceutical purposes; ointment for pharmace...
G/S Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid dr...
G/S Antibiotics for suspension
G/S Cefalexin for suspension.
2010 G/S Medicines for human purposes; medicines based on raw materials; troche for pharmaceutical purpos...